Hormonal control in a state of decreased activation: potentiation of arginine vasopressin secretion.
J. P. O'Halloran, R. Jevning, A. Wilson, R. Skowsky, Roger Walsh, Charles N. Alexander
Physiology & Behavior October 1, 1985 DOI: 10.1016/0031-9384(85)90146-5 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | Long-term practitioners of transcendental meditation (6-8 years of regular practice) and a separate group of subjects undergoing ordinary eyes-closed rest |
| Intervention | Transcendental meditation |
| Measures | Galvanic skin resistance (GSR), Spielberger Anxiety Inventory |
| Key findings | Transcendental meditation in long-term practitioners produced a phasic rise in plasma arginine vasopressin to 2.6-7.1 times normal concentrations without increased plasma osmolality, while ordinary eyes-closed rest was associated with normal AVP. The authors argue that neither stress nor usual homeostatic mechanisms explain this elevation and speculate that a mechanism specific to meditation's behavioral effects may be involved. |
Abstract
Behaviorally induced stress is associated with increased arginine vasopressin (AVP) secretion. In this report we describe a phasic conditioned response of AVP secretion yielding 2.6-7.1 times normal plasma concentration of this hormone in association with a physiological state of decreased activation, that associated with the mental technique of "transcendental meditation" (TM) in long-term practitioners (6-8 years of regular elicitation). Such a very large phasic response of AVP was previously unknown in the normal physiology of AVP. This elevation was not accompanied by elevation of plasma osmolality. Unstylized ordinary eyes closed rest in a separate group of subjects studied in the same manner was associated with normal plasma AVP concentration. Galvanic skin resistance (GSR) increased during both TM and rest with significantly larger increase associated with TM. Other measures of activation, including muscle metabolism, and the Spielberger Anxiety Inventory indicated marked relaxation in association with TM. In previous research it has been shown that blood pressure does not change acutely during this behavior. These observations indicate that neither stress nor operation of other usual homeostatic control mechanisms are responsible for elevated for AVP in the meditators. It is speculated that the apparently unique mechanism of TM-induced AVP secretion may be more specifically related to the behavioral effects of meditation.
Citations in the library
Cited by 14
- Transcendental Meditation, mindfulness, and longevity: An experimental study with the elderly. Journal of Personality and Social Psychology 1989
- An analysis of recent meditation research and suggestions for future directions. The Humanistic Psychologist 2003
- The neuroscientific study of spiritual practices Frontiers in Psychology March 18, 2014
- Mechanisms of Yogic Practices in Health, Aging, and Disease Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine September 1, 2010
- Changes in peripheral oxytocin and vasopressin during a silent month-long Insight meditation retreat. Frontiers in Endocrinology 2024
and 9 more in the library
Cites 5
- Transcendental Meditation and Psychological Health Perceptual and Motor Skills October 1, 1974
- Influence of Transcendental Meditation upon Autokinetic Perception Perceptual and Motor Skills December 1, 1974
- Psychotherapeutic effects of transcendental meditation with controls for expectation of relief and daily sitting. Journal of Consulting and Clinical Psychology 1976
- Renin, Cortisol, and Aldosterone During Transcendental Meditation Psychosomatic Medicine February 1, 1979
- Redistribution of blood flow in acute hypometabolic behavior. American Journal of Physiology-Legacy Content July 1978